Literature DB >> 28472339

Foreword: Biomarkers and Surrogate Endpoints in Ophthalmic Clinical Research.

Edoardo Villani1, Stela Vujosevic1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28472339     DOI： 10.1167/iovs.17-22128

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  5 in total

1.  Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study.

Authors:  Laura Kowalczuk; Alexandre Matet; Marianne Dor; Nasim Bararpour; Alejandra Daruich; Ali Dirani; Francine Behar-Cohen; Aurélien Thomas; Natacha Turck
Journal:  Transl Vis Sci Technol       Date:  2018-01-18       Impact factor: 3.283

2.  Lactoferrin Concentration in Human Tears and Ocular Diseases: A Meta-Analysis.

Authors:  Erika Ponzini; Lorenza Scotti; Rita Grandori; Silvia Tavazzi; Antonella Zambon
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

3.  Method for the biomechanical analysis of aqueous veins and perilimbal sclera by three-dimensional photoacoustic imaging and strain field calculation.

Authors:  Linyu Ni; John Riesterer; Huaizhou Wang; Layla Berry; Kara Blackburn; Jonathan Chuang; Wonsuk Kim; Guan Xu; Sayoko E Moroi; Alan Argento
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

4.  Multimodal imaging including semiquantitative short-wavelength and near-infrared autofluorescence in achromatopsia.

Authors:  Alexandre Matet; Susanne Kohl; Britta Baumann; Aline Antonio; Saddek Mohand-Said; José-Alain Sahel; Isabelle Audo
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

5.  Clinically Relevant Immune-Cellular Metrics of Inflammation in Meibomian Gland Dysfunction.

Authors:  Yureeda Qazi; Ahmad Kheirkhah; Caroline Blackie; Monique Trinidad; Candice Williams; Andrea Cruzat; Donald R Korb; Pedram Hamrah
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.